Celularity, Inc. (CELU)
1.01
+0.02
(+1.92%)
USD |
NASDAQ |
May 29, 16:00
1.02
+0.01
(+0.99%)
After-Hours: 20:00
Celularity Profit Margin (Quarterly) : -593.6% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Tenax Therapeutics, Inc. | -- |
| Exicure, Inc. | -- |
| Century Therapeutics, Inc. | -- |
| Absci Corp. | -13.77K% |
| Cardio Diagnostics Holdings, Inc. | -66.23K% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -46.78% |
| Return on Invested Capital | -169.9% |
| Gross Profit Margin (Quarterly) | -123.6% |
| Operating Margin (Quarterly) | -537.5% |
| Return on Net Operating Assets | -86.11% |